Copyright © Inderes 2011 - present. All rights reserved.
  • Latest
  • Markets
    • Stock Comparison
    • Financial Calendar
    • Dividends Calendar
    • Research
    • Articles
  • inderesTV
  • Portfolio
  • Forum
  • Q&A
  • About Us
    • Our Coverage
    • Team

Prolight Diagnostics

20.95 SEK

+0.96 %

Less than 1K followers

PRLD

Nordic SME

Medical Equipment & Services

Health Care

Overview
Financials & Estimates
Ownership
Investor consensus
Compare
+0.96 %
+5.81 %
-11.60 %
-10.85 %
+70.80 %
+57.85 %
+19.21 %
-87.37 %
-46.77 %

Prolight Diagnostics develops point-of-care (POC) systems. These are small mobile instruments with disposable test cards that can perform In-Vitro Diagnostic (IVD) tests from a drop of blood. The POC system can contribute to faster and more accurate diagnoses of acute conditions. The company's launch product will be a highly sensitive measurement of troponin to be able to determine and exclude heart attacks.

Read more
Market cap
252.34M SEK
Turnover
144.03K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
26/2
2026

Annual report '25

26/5
2026

Interim report Q1'26

26/5
2026

General meeting '26

All
Webcasts
Press releases
3rd party
ShowingAll content types
Press release12/11/2025, 7:30 AM

Prolight säkrar tredje europeiska patentet för Psyros™

Prolight Diagnostics
Press release12/11/2025, 7:30 AM

Prolight secures third patent in Europe for Psyros™

Prolight Diagnostics
Press release12/8/2025, 8:30 AM

BioStock publicerar artikel som beskriver hur Prolight Diagnostics förbereder den kliniska studien

Prolight Diagnostics

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Press release12/8/2025, 8:30 AM

BioStock publishes an article describing how Prolight Diagnostics is preparing the clinical study

Prolight Diagnostics
Press release12/8/2025, 6:25 AM

BioStock: Prolights CTO sätter fokus på CRO-partnern MDx

Prolight Diagnostics
Press release12/8/2025, 6:25 AM

BioStock: Prolight's CTO focuses on CRO partner MDx

Prolight Diagnostics
Regulatory press release12/5/2025, 10:00 AM

VALBEREDNINGEN I PROLIGHT DIAGNOSTICS UTSEDD INFÖR ÅRSSTÄMMAN 2026

Prolight Diagnostics
Regulatory press release12/5/2025, 10:00 AM

THE NOMINATION COMMITTEE APPOINTED FOR THE ANNUAL GENERAL MEETING 2026

Prolight Diagnostics
Regulatory press release12/4/2025, 9:00 AM

Prolight offentliggör tidsplan för sammanläggning av aktier

Prolight Diagnostics
Regulatory press release12/4/2025, 9:00 AM

Prolight announces timetable for share reverse split

Prolight Diagnostics
Regulatory press release11/27/2025, 7:00 AM

Prolight Diagnostics publicerar delårsrapport Q3, 2025

Prolight Diagnostics
Regulatory press release11/27/2025, 7:00 AM

Prolight Diagnostics publishes quarterly report Q3, 2025

Prolight Diagnostics
Regulatory press release11/19/2025, 1:45 PM

Extra bolagsstämma i Prolight Diagnostics AB (publ) den 19 november 2025

Prolight Diagnostics
Regulatory press release11/19/2025, 1:45 PM

Extraordinary general meeting of Prolight Diagnostics AB (publ) on 19 November 2025

Prolight Diagnostics
Press release11/17/2025, 11:40 AM

BioStock publicerar artikel om Prolight Diagnostics fortsatta förberedelser inför marknadslanseringen av Psyros-plattformen

Prolight Diagnostics
Press release11/17/2025, 11:40 AM

BioStock publishes article about Prolight Diagnostics continued preparations to bring the Psyros platform to market

Prolight Diagnostics
Press release11/17/2025, 10:26 AM

BioStock: Slutjusteringar och validering i fokus hos Prolight Diagnostics

Prolight Diagnostics
Press release11/17/2025, 10:26 AM

BioStock: Final adjustments and validation take center stage at Prolight Diagnostics

Prolight Diagnostics
Press release11/5/2025, 1:55 PM

Prolight Diagnostics publishes investor letter for November 2025

Prolight Diagnostics
Press release11/5/2025, 1:55 PM

Prolight Diagnostics publicerar investerarbrev för November 2025

Prolight Diagnostics
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.